Precision measurement company Mettler-Toledo (NYSE: MTD) announced better-than-expected revenue in Q1 CY2026, with sales up 7.2% year on year to $947.1 million. Its non-GAAP profit of $8.91 per share was 2.3% above analysts’ consensus estimates.

Is now the time to buy Mettler-Toledo? Find out by accessing our full research report, it’s free.

Company Overview

With roots dating back to the precision balance innovations of Swiss engineer Erhard Mettler, Mettler-Toledo (NYSE: MTD) manufactures precision weighing instruments, analytical equipment, and product inspection systems used in laboratories, industrial settings, and food retail.

Revenue Growth

A company’s long-term performance is an indicator of its overall quality. Even a bad business can shine for one or two quarters, but a top-tier one grows for years. Unfortunately, Mettler-Toledo’s 4.8% annualized revenue growth over the last five years was mediocre. This was below our standard for the healthcare sector and is a poor baseline for our analysis.

Long-term growth is the most important, but within healthcare, a half-decade historical view may miss new innovations or demand cycles. Mettler-Toledo’s annualized revenue growth of 3.9% over the last two years aligns with its five-year trend, suggesting its demand was consistently weak.

This quarter, Mettler-Toledo reported year-on-year revenue growth of 7.2%, and its $947.1 million of revenue exceeded Wall Street’s estimates by 0.6%.

Looking ahead, sell-side analysts expect revenue to grow 4.6% over the next 12 months, similar to its two-year rate. This projection doesn't excite us and suggests its newer products and services will not lead to better top-line performance yet.

ONE MORE THING: The $21 AI Application Stock Wall Street Forgot. While Wall Street obsesses over who’s building AI, one company is already using it to print money. And nobody’s paying attention.

AI chip stocks trade at ridiculous valuations. This company processes a trillion consumer signals monthly using AI and trades at a third of the price. The gap won’t last. The institutions will figure it out. You need to see this first. Read the FREE Report Before They Notice.

Adjusted Operating Margin

Mettler-Toledo’s adjusted operating margin has more or less stayed the same over the last 12 months , averaging 29.7% over the last five years. This profitability was top-notch for a healthcare business, showing it’s an well-run company with an efficient cost structure.

Looking at the trend in its profitability, Mettler-Toledo’s adjusted operating margin of 28.6% for the trailing 12 months may be around the same as five years ago, but it has decreased by 1.8 percentage points over the last two years.

This quarter, Mettler-Toledo generated an adjusted operating margin profit margin of 22.7%, down 4.1 percentage points year on year. This contraction shows it was less efficient because its expenses grew faster than its revenue.

Earnings Per Share

We track the long-term change in earnings per share (EPS) for the same reason as long-term revenue growth. Compared to revenue, however, EPS highlights whether a company’s growth is profitable.

Mettler-Toledo’s EPS grew at 9.1% compounded annual growth rate over the last five years, higher than its 4.8% annualized revenue growth. However, this alone doesn’t tell us much about its business quality because its adjusted operating margin didn’t improve.

Diving into the nuances of Mettler-Toledo’s earnings can give us a better understanding of its performance. A five-year view shows that Mettler-Toledo has repurchased its stock, shrinking its share count by 14.1%. This tells us its EPS outperformed its revenue not because of increased operational efficiency but financial engineering, as buybacks boost per share earnings.

In Q1, Mettler-Toledo reported adjusted EPS of $8.91, up from $8.19 in the same quarter last year. This print beat analysts’ estimates by 2.3%. Over the next 12 months, Wall Street expects Mettler-Toledo’s full-year EPS of $43.51 to grow 10.2%.

Key Takeaways from Mettler-Toledo’s Q1 Results

It was good to see Mettler-Toledo narrowly top analysts’ revenue expectations this quarter. On the other hand, its EPS guidance for next quarter missed. Overall, this was a weaker quarter. The stock traded down 4.6% to $1,260 immediately following the results.

So should you invest in Mettler-Toledo right now? What happened in the latest quarter matters, but not as much as longer-term business quality and valuation, when deciding whether to invest in this stock. We cover that in our actionable full research report which you can read here (it’s free).